Nancy Simonian
Chief Executive Officer en SYROS PHARMACEUTICALS, INC. .
Fortuna: 704 370 $ al 31/03/2024
Perfil
Nancy A.
Simonian is currently the Director at the Biotechnology Innovation Organization since 2015, the Director at The Damon Runyon Cancer Research Foundation since 2014, and the Director at Syros Pharmaceuticals, Inc. since 2012.
Previously, she worked as the Director at ArQule, Inc. from 2006 to 2011, the Independent Director at Seagen Inc. from 2012 to 2023, and as the Chief Medical Officer & SVP-Regulatory Affairs at Millennium Pharmaceuticals, Inc. from 2001 to 2011.
She also held positions at Biogen, Inc. as the Vice President-Clinical Development from 1995 to 2001, and as a Faculty Member at The General Hospital Corp.
She has also worked as an Assistant Professor at the Massachusetts General Hospital Cancer Center and Harvard Medical School.
Dr. Simonian completed her undergraduate degree at Princeton University in 1983 and received her doctorate from the Perelman School of Medicine at the University of Pennsylvania in 1988.
She also holds a doctorate from the University of Pennsylvania Medical Center.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2024 | 131 658 ( 0.51% ) | 704 370 $ | 31/03/2024 |
Cargos activos de Nancy Simonian
| Empresas | Cargo | Inicio |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Executive Officer | 01/11/2012 |
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Director/Board Member | 01/10/2014 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 06/07/2015 |
Antiguos cargos conocidos de Nancy Simonian.
| Empresas | Cargo | Fin |
|---|---|---|
| SEAGEN INC. | Director/Board Member | 14/12/2023 |
| EVELO BIOSCIENCES, INC. | Director/Board Member | 10/06/2021 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/10/2011 |
| ARQULE, INC. | Director/Board Member | 31/03/2011 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2001 |
Formación de Nancy Simonian.
| Princeton University | Undergraduate Degree |
| Perelman School of Medicine | Doctorate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Commercial Services |
Massachusetts General Hospital Cancer Center
 Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Health Services |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Commercial Services |
- Bolsa de valores
- Insiders
- Nancy Simonian
